MYNZ
Mainz Biomed NV
Price Chart
No historical data available
Latest Quote
$0.84
+0.02 (+2.71%)
Current Price
| Previous Close | $0.82 |
| Open | $0.80 |
| Day High | $0.86 |
| Day Low | $0.74 |
| Volume | 5,235,144 |
Stock Information
| Shares Outstanding | 12.52M |
| Total Debt | $3.09M |
| Cash Equivalents | $1.91M |
| Revenue | $660K |
| Net Income | $-18.97M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $10.56M |
| EPS (TTM) | $-5.28 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Mainz Biomed NV
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.
đ° Latest News
No news articles available at the moment. Check back later for updates on MYNZ.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $319,108 | $385,820 | $123,166 | $368,180 |
| Cost Of Revenue | $319,108 | $385,820 | $347,726 | $399,726 |
| Total Revenue | $893,991 | $895,479 | $529,877 | $577,348 |
| Operating Revenue | $893,991 | $895,479 | $529,877 | $577,348 |
| Expenses | ||||
| Interest Expense | $1,075,232 | $559,581 | $289,324 | $339,171 |
| Total Expenses | $19,312,239 | $27,540,161 | $26,973,917 | $10,301,954 |
| Other Income Expense | $-2,157,183 | $1,158,536 | $346,028 | $-1,626,321 |
| Other Non Operating Income Expenses | $-1,908,351 | $1,109,859 | $346,028 | $393,418 |
| Net Non Operating Interest Income Expense | $-1,075,232 | $-809,581 | $-289,324 | $-339,171 |
| Interest Expense Non Operating | $1,075,232 | $559,581 | $289,324 | $339,171 |
| Operating Expense | $18,993,131 | $27,154,341 | $26,626,191 | $9,902,228 |
| Selling And Marketing Expense | $4,695,285 | $3,803,351 | $5,018,728 | $626,366 |
| General And Administrative Expense | $8,079,637 | $13,418,194 | $16,432,859 | $8,755,545 |
| Total Other Finance Cost | - | $250,000 | - | $139,974 |
| Other Operating Expenses | - | - | $-269,286 | $-350,407 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Interest Income | $-1,075,232 | $-809,581 | $-289,324 | $-339,171 |
| Normalized Income | $-21,401,831 | $-26,344,404 | $-26,387,336 | $-9,670,359 |
| Net Income From Continuing And Discontinued Operation | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Total Operating Income As Reported | $-18,695,408 | $-26,644,682 | $-26,444,040 | $-9,724,606 |
| Net Income Common Stockholders | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Income | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Income Including Noncontrolling Interests | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Income Continuous Operations | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Pretax Income | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Special Income Charges | $-248,832 | $48,677 | $0 | $-2,019,739 |
| Operating Income | $-18,418,248 | $-26,644,682 | $-26,444,040 | $-9,724,606 |
| Depreciation Amortization Depletion Income Statement | $379,176 | $342,403 | $155,238 | $38,383 |
| Depreciation And Amortization In Income Statement | $379,176 | $342,403 | $155,238 | $38,383 |
| Gross Profit | $574,883 | $509,659 | $182,151 | $177,622 |
| Depreciation Income Statement | - | - | - | $29,515 |
| Per Share | ||||
| Diluted EPS | $-22.36 | $-64.76 | $-74.55 | $-64.80 |
| Basic EPS | $-22.36 | $-64.76 | $-74.55 | $-64.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-19,309,562 | $-24,918,411 | $-25,718,214 | $-9,261,259 |
| Total Unusual Items | $-248,832 | $48,677 | $0 | $-2,019,739 |
| Total Unusual Items Excluding Goodwill | $-248,832 | $48,677 | $0 | $-2,019,739 |
| Reconciled Depreciation | $1,017,037 | $866,412 | $379,798 | $69,929 |
| EBITDA (Bullshit earnings) | $-19,558,394 | $-24,869,734 | $-25,718,214 | $-11,280,998 |
| EBIT | $-20,575,431 | $-25,736,146 | $-26,098,012 | $-11,350,927 |
| Diluted Average Shares | $968,234 | $406,058 | $353,937 | $180,272 |
| Basic Average Shares | $968,234 | $406,058 | $353,937 | $180,272 |
| Diluted NI Availto Com Stockholders | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Business | $28,328 | $0 | $0 | - |
| Write Off | $47,449 | $0 | $0 | $0 |
| Restructuring And Mergern Acquisition | $229,711 | $0 | $0 | $2,019,739 |
| Research And Development | $5,839,033 | $9,590,393 | $5,019,366 | $481,934 |
| Selling General And Administration | $12,774,922 | $17,221,545 | $21,451,587 | $9,381,911 |
| Other Gand A | $3,891,563 | $5,580,524 | $3,820,717 | $1,254,478 |
| Insurance And Claims | $536,546 | $817,181 | $920,121 | $170,464 |
| Salaries And Wages | $3,651,528 | $7,020,489 | $11,692,021 | $7,330,603 |
| Other Special Charges | - | $-48,677 | - | - |
Fetched: 2026-03-10
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,029,081 | $-145,419 | $14,096,067 | $6,361,155 |
| Total Assets | $13,238,167 | $15,409,028 | $20,241,003 | $10,040,795 |
| Total Non Current Assets | $5,394,137 | $6,429,132 | $1,862,662 | $431,586 |
| Goodwill And Other Intangible Assets | $3,017,462 | $3,394,645 | $0 | $0 |
| Current Assets | $7,844,030 | $8,979,896 | $18,378,341 | $9,609,209 |
| Prepaid Assets | $1,021,745 | $940,715 | $801,959 | $769,825 |
| Inventory | $372,870 | $613,638 | $175,469 | $0 |
| Receivables | $213,745 | $354,510 | $259,138 | $111,842 |
| Taxes Receivable | $162,930 | $260,955 | $192,154 | $94,085 |
| Accounts Receivable | $33,577 | $93,555 | $63,736 | $17,199 |
| Allowance For Doubtful Accounts Receivable | $0 | $-28,180 | $-66,852 | $-796 |
| Gross Accounts Receivable | $33,577 | $121,735 | $130,588 | $17,995 |
| Cash Cash Equivalents And Short Term Investments | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Cash And Cash Equivalents | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Cash Financial | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Other Non Current Assets | - | $108 | $23,275 | - |
| Other Current Assets | - | $108 | - | - |
| Other Receivables | - | - | $3,248 | $558 |
| Debt | ||||
| Total Debt | $3,271,381 | $7,420,780 | $3,228,257 | $2,576,394 |
| Long Term Debt And Capital Lease Obligation | $865,982 | $2,195,889 | $1,902,330 | $2,327,885 |
| Current Debt And Capital Lease Obligation | $2,405,399 | $5,224,891 | $1,325,927 | $248,509 |
| Current Debt | $2,125,254 | $4,936,428 | $1,040,573 | $193,433 |
| Other Current Borrowings | $2,125,254 | $4,936,428 | $1,040,573 | $193,433 |
| Long Term Debt | - | $1,030,166 | $943,214 | $1,940,119 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,191,624 | $12,159,802 | $6,144,936 | $3,679,640 |
| Total Non Current Liabilities Net Minority Interest | $1,242,078 | $2,922,866 | $1,902,330 | $2,327,885 |
| Other Non Current Liabilities | $376,096 | $726,977 | - | - |
| Current Liabilities | $5,949,546 | $9,236,936 | $4,242,606 | $1,351,755 |
| Other Current Liabilities | $690,575 | $388,839 | - | - |
| Current Deferred Liabilities | $0 | $138,889 | $199,410 | - |
| Payables And Accrued Expenses | $2,853,572 | $3,484,317 | $2,717,269 | $1,103,246 |
| Payables | $1,812,701 | $2,626,375 | $1,333,044 | $835,735 |
| Accounts Payable | $1,254,187 | $2,326,439 | $1,333,044 | $832,518 |
| Total Tax Payable | - | - | $0 | $3,217 |
| Derivative Product Liabilities | - | - | - | $1,940,119 |
| Other Payable | - | - | - | $233,710 |
| Equity | ||||
| Common Stock Equity | $6,046,543 | $3,249,226 | $14,096,067 | $6,361,155 |
| Total Equity Gross Minority Interest | $6,046,543 | $3,249,226 | $14,096,067 | $6,361,155 |
| Stockholders Equity | $6,046,543 | $3,249,226 | $14,096,067 | $6,361,155 |
| Gains Losses Not Affecting Retained Earnings | $27,038,075 | $20,833,903 | $18,131,923 | $9,738,545 |
| Other Equity Adjustments | $27,038,075 | $20,833,903 | $18,131,923 | $9,738,545 |
| Retained Earnings | $-90,978,684 | $-69,328,021 | $-43,032,294 | $-16,644,958 |
| Other | ||||
| Ordinary Shares Number | $2,319,353 | $529,137 | $365,736 | $300,250 |
| Share Issued | $2,319,353 | $529,137 | $365,736 | $300,250 |
| Tangible Book Value | $3,029,081 | $-145,419 | $14,096,067 | $6,361,155 |
| Invested Capital | $8,171,797 | $9,215,820 | $16,079,854 | $8,494,707 |
| Working Capital | $1,894,484 | $-257,040 | $14,135,735 | $8,257,454 |
| Capital Lease Obligations | $1,146,127 | $1,454,186 | $1,244,470 | $442,842 |
| Total Capitalization | $6,046,543 | $4,279,392 | $15,039,281 | $8,301,274 |
| Additional Paid In Capital | $69,065,027 | $51,507,526 | $38,831,542 | $13,126,493 |
| Capital Stock | $922,125 | $235,818 | $164,896 | $141,075 |
| Common Stock | $922,125 | $235,818 | $164,896 | $141,075 |
| Long Term Capital Lease Obligation | $865,982 | $1,165,723 | $959,116 | $387,766 |
| Current Deferred Revenue | $0 | $138,889 | $199,410 | - |
| Current Capital Lease Obligation | $280,145 | $288,463 | $285,354 | $55,076 |
| Current Accrued Expenses | $1,040,871 | $857,942 | $1,384,225 | $267,511 |
| Dueto Related Parties Current | $558,514 | $299,936 | - | - |
| Net PPE | $2,376,675 | $3,034,487 | $1,839,387 | $431,586 |
| Accumulated Depreciation | $-1,345,689 | $-895,097 | $-472,535 | $-218,775 |
| Gross PPE | $3,722,364 | $3,929,584 | $2,311,922 | $650,361 |
| Construction In Progress | $0 | $59,929 | $0 | - |
| Other Properties | $1,505,887 | $1,588,794 | $942,141 | $100,767 |
| Machinery Furniture Equipment | $612,376 | $616,224 | $334,581 | $60,451 |
| Buildings And Improvements | $1,604,101 | $1,664,637 | $1,035,200 | $489,143 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-25,059 | $-56,833 | $0 | - |
| Finished Goods | $84,253 | $240,467 | $0 | - |
| Raw Materials | $313,676 | $430,004 | $175,469 | - |
| Duefrom Related Parties Current | $17,238 | $0 | - | - |
| Leases | - | - | - | $489,143 |
Fetched: 2026-03-10
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-17,344,960 | $-23,837,686 | $-15,428,073 | $-3,237,029 |
| Operating Activities | ||||
| Operating Cash Flow | $-17,090,011 | $-21,938,845 | $-14,769,590 | $-3,220,324 |
| Cash Flow From Continuing Operating Activities | $-17,090,011 | $-21,938,845 | $-14,769,590 | $-3,220,324 |
| Operating Gains Losses | $-75,147 | $-48,677 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-254,949 | $-1,898,841 | $-658,483 | $-16,705 |
| Investing Cash Flow | $-198,817 | $-1,898,841 | $-658,483 | $1,203,151 |
| Cash Flow From Continuing Investing Activities | $-198,817 | $-1,898,841 | $-658,483 | $1,203,151 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $13,764,717 | $6,392,751 | $23,865,889 | $10,425,160 |
| Financing Cash Flow | $16,599,629 | $14,226,692 | $23,943,418 | $10,610,534 |
| Cash Flow From Continuing Financing Activities | $16,599,629 | $14,226,692 | $23,943,418 | $10,610,534 |
| Net Common Stock Issuance | $13,764,717 | $6,392,751 | $23,865,889 | $10,425,160 |
| Common Stock Issuance | $13,764,717 | $6,392,751 | $23,865,889 | $10,425,160 |
| Other | ||||
| Repayment Of Debt | $-1,475,088 | $-2,286,059 | $-304,971 | $-61,240 |
| Issuance Of Debt | $4,310,000 | $10,120,000 | $0 | $246,614 |
| Interest Paid Supplemental Data | $198,061 | $153,580 | $125,543 | $46,240 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | - |
| End Cash Position | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Beginning Cash Position | $7,070,925 | $17,141,775 | $8,727,542 | $122,568 |
| Effect Of Exchange Rate Changes | $-146,056 | $-459,856 | $-101,112 | $11,613 |
| Changes In Cash | $-689,199 | $-9,610,994 | $8,515,345 | $8,593,361 |
| Proceeds From Stock Option Exercised | $0 | $0 | $382,500 | $0 |
| Net Issuance Payments Of Debt | $2,834,912 | $7,833,941 | $-304,971 | $185,374 |
| Net Short Term Debt Issuance | $3,130,167 | $9,020,000 | $0 | $7,673 |
| Short Term Debt Payments | $-1,179,833 | $-1,100,000 | $0 | $0 |
| Short Term Debt Issuance | $4,310,000 | $10,120,000 | $0 | $7,673 |
| Net Long Term Debt Issuance | $-295,255 | $-1,186,059 | $-304,971 | $177,701 |
| Long Term Debt Payments | $-295,255 | $-1,186,059 | $-304,971 | $-61,240 |
| Net Business Purchase And Sale | $32,785 | $0 | $0 | $1,219,856 |
| Sale Of Business | $32,785 | $0 | $0 | $1,219,856 |
| Net Intangibles Purchase And Sale | $-150,000 | $-700,000 | $0 | - |
| Purchase Of Intangibles | $-150,000 | $-700,000 | $0 | - |
| Net PPE Purchase And Sale | $-81,602 | $-1,198,841 | $-658,483 | $-16,705 |
| Sale Of PPE | $23,347 | $0 | $0 | - |
| Purchase Of PPE | $-104,949 | $-1,198,841 | $-658,483 | $-16,705 |
| Change In Working Capital | $51,746 | $-64,630 | $1,387,006 | $-138,616 |
| Change In Other Working Capital | $-135,724 | $-60,521 | $173,902 | $11,080 |
| Change In Payables And Accrued Expense | $84,610 | $720,237 | $1,650,500 | $659,645 |
| Change In Prepaid Assets | $8,771 | $-239,703 | $-53,788 | $-833,556 |
| Change In Inventory | $29,811 | $-500,187 | $-172,377 | $0 |
| Change In Receivables | $64,278 | $15,544 | $-211,231 | $24,215 |
| Other Non Cash Items | $156,717 | $168,109 | $-38,604 | $2,108,303 |
| Stock Based Compensation | $1,136,430 | $4,005,629 | $9,824,157 | $6,430,158 |
| Unrealized Gain Loss On Investment Securities | $2,052,000 | $-661,000 | $0 | $0 |
| Asset Impairment Charge | $221,869 | $91,039 | $65,389 | $0 |
| Depreciation Amortization Depletion | $1,017,037 | $866,412 | $379,798 | $69,929 |
| Depreciation And Amortization | $1,017,037 | $866,412 | $379,798 | $69,929 |
| Gain Loss On Sale Of PPE | $-46,818 | $0 | $0 | - |
| Gain Loss On Sale Of Business | $-28,329 | $0 | $0 | - |
| Net Income From Continuing Operations | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Long Term Debt Issuance | - | $0 | $0 | $238,941 |
| Changes In Account Receivables | - | - | - | $24,215 |
Fetched: 2026-03-10